These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 27143243)

  • 1. The complex relationship between CD4 count, HIV viral load, trimethoprim-sulfamethoxazole prophylaxis, and skin-and-soft-tissue infection risk in patients with HIV: insights from a causal diagram and simulation study.
    Hemmige V; Lauderdale DS; David MZ
    Epidemiol Infect; 2016 Oct; 144(13):2889-98. PubMed ID: 27143243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of skin and soft tissue infections in HIV-infected outpatients in the community-associated methicillin-resistant Staphylococcus aureus era.
    Hemmige V; McNulty M; Silverman E; David MZ
    Eur J Clin Microbiol Infect Dis; 2015 Feb; 34(2):339-47. PubMed ID: 25213720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community-onset methicillin-resistant Staphylococcus aureus in an urban HIV clinic.
    Skiest D; Brown K; Hester J; Moore T; Crosby C; Mussa HR; Hoffman-Roberts H; Cooper T
    HIV Med; 2006 Sep; 7(6):361-8. PubMed ID: 16903980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent skin and soft tissue infections in HIV-infected patients during a 5-year period: incidence and risk factors in a retrospective cohort study.
    Hemmige V; McNulty M; Silverman E; David MZ
    BMC Infect Dis; 2015 Oct; 15():455. PubMed ID: 26503616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent community-associated methicillin-resistant Staphylococcus aureus infections among HIV-infected persons: incidence and risk factors.
    Crum-Cianflone N; Weekes J; Bavaro M
    AIDS Patient Care STDS; 2009 Jul; 23(7):499-502. PubMed ID: 19530952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and therapeutic evaluation of community-acquired methicillin-resistant Staphylococcus Aureus (MRSA) skin and soft tissue infections in the emergency department.
    Walraven CJ; Lingenfelter E; Rollo J; Madsen T; Alexander DP
    J Emerg Med; 2012 Apr; 42(4):392-9. PubMed ID: 21524884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Has the emergence of community-associated methicillin-resistant Staphylococcus aureus increased trimethoprim-sulfamethoxazole use and resistance?: a 10-year time series analysis.
    Wood JB; Smith DB; Baker EH; Brecher SM; Gupta K
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5655-60. PubMed ID: 22908161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community-associated methicillin-resistant Staphylococcus aureus skin and soft-tissue infection in HIV-infected patients.
    Trinh TT; Short WR; Mermel LA
    J Int Assoc Physicians AIDS Care (Chic); 2009; 8(3):176-80. PubMed ID: 19423878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The rise of methicillin resistant Staphylococcus aureus: now the dominant cause of skin and soft tissue infection in Central Australia.
    Macmorran E; Harch S; Athan E; Lane S; Tong S; Crawford L; Krishnaswamy S; Hewagama S
    Epidemiol Infect; 2017 Oct; 145(13):2817-2826. PubMed ID: 28803587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upward trend in the frequency of community-acquired methicillin-resistant Staphylococcus aureus as a cause of pediatric skin and soft tissue infections over five years: a cross-sectional study.
    Böncüoğlu E; Kıymet E; Çağlar İ; Oruç Y; Demiray N; Kara AA; Erdem T; Gülfidan G; Devrim İ; Bayram N
    Turk J Pediatr; 2021; 63(2):200-205. PubMed ID: 33929109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in prescriptive practices in skin and soft tissue infections associated with the increased occurrence of community acquired methicillin resistant Staphylococcus aureus.
    Meddles-Torres C; Hu S; Jurgens C
    J Infect Public Health; 2013 Dec; 6(6):423-30. PubMed ID: 23999333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of community-associated Staphylococcus aureus, methicillin-resistant and methicillin-susceptible Staphylococcus aureus skin and soft tissue infections in primary-care settings.
    Lee GC; Hall RG; Boyd NK; Dallas SD; Du LC; Treviño LB; Retzloff C; Treviño SB; Lawson KA; Wilson JP; Olsen RJ; Wang Y; Frei CR
    Epidemiol Infect; 2016 Nov; 144(15):3198-3204. PubMed ID: 27489019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose of trimethoprim-sulfamethoxazole to treat skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus.
    Cadena J; Nair S; Henao-Martinez AF; Jorgensen JH; Patterson JE; Sreeramoju PV
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5430-2. PubMed ID: 21930870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin and Soft Tissue Infection in People Living With Human Immunodeficiency Virus in a Large, Urban, Public Healthcare System in Houston, Texas, 2009-2014.
    Hemmige V; Arias CA; Pasalar S; Giordano TP
    Clin Infect Dis; 2020 Apr; 70(9):1985-1992. PubMed ID: 31209457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence, severity, and treatment of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) skin and soft tissue infections in 10 medical clinics in Texas: a South Texas Ambulatory Research Network (STARNet) study.
    Forcade NA; Parchman ML; Jorgensen JH; Du LC; Nyren NR; Treviño LB; Peña J; Mann MW; Muñoz A; Treviño SB; Mortensen EM; Wickes BL; Pollock BH; Frei CR
    J Am Board Fam Med; 2011; 24(5):543-50. PubMed ID: 21900437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing rates of community-acquired methicillin-resistant Staphylococcus aureus infections among HIV-infected persons.
    Crum-Cianflone NF; Burgi AA; Hale BR
    Int J STD AIDS; 2007 Aug; 18(8):521-6. PubMed ID: 17686212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methicillin-resistant Staphylococcus aureus in skin and soft tissue infections presenting to the Emergency Department of a Canadian Academic Health Care Center.
    Achiam CC; Fernandes CM; McLeod SL; Salvadori MI; John M; Seabrook JA; Theakston KD; Milburn S; Hussain Z
    Eur J Emerg Med; 2011 Feb; 18(1):2-8. PubMed ID: 20168235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community-associated methicillin-resistant Staphylococcus aureus and HIV: intersecting epidemics.
    Popovich KJ; Weinstein RA; Aroutcheva A; Rice T; Hota B
    Clin Infect Dis; 2010 Apr; 50(7):979-87. PubMed ID: 20192731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High incidence of antimicrobial resistant organisms including extended spectrum beta-lactamase producing Enterobacteriaceae and methicillin-resistant Staphylococcus aureus in nasopharyngeal and blood isolates of HIV-infected children from Cape Town, South Africa.
    Cotton MF; Wasserman E; Smit J; Whitelaw A; Zar HJ
    BMC Infect Dis; 2008 Apr; 8():40. PubMed ID: 18380900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferred treatment and prevention strategies for recurrent community-associated methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: a survey of adult and pediatric providers.
    Mascitti KB; Gerber JS; Zaoutis TE; Barton TD; Lautenbach E
    Am J Infect Control; 2010 May; 38(4):324-8. PubMed ID: 20420965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.